A purity percentage on a product page is only useful when it can be traced to the exact vial or batch being offered. Knowing how to assess peptide purity means looking beyond a headline figure and checking the analytical evidence, batch reference and supplier controls behind it. For research buyers, that distinction is what separates a documented material from an unsupported claim.
What peptide purity actually tells you
Peptide purity is usually expressed as the proportion of the target compound present in a tested sample. A result of 99% purity means that, under the stated analytical method, the target peptide accounted for approximately 99% of the detected material. It does not mean that every aspect of quality has been proven by that one number alone.
Purity, identity, quantity and physical condition are related but separate checks. A high-performance liquid chromatography result may indicate the relative purity profile of a sample. It does not, by itself, confirm molecular identity, confirm the exact fill quantity of every vial, or show how the product was handled after testing. A credible assessment joins these points together rather than treating one percentage as a complete quality verdict.
This matters especially when comparing apparently similar listings. Two suppliers may both state 99% purity, but only one may provide a batch-specific Certificate of Analysis, a chromatogram, analytical method details and a label reference that matches the paperwork. The second claim is easier to print. The first is easier to verify.
How to assess peptide purity from a COA
A Certificate of Analysis, commonly called a COA, should be the starting document. It records the results for a defined batch, rather than making a broad claim about a product type. Before relying on it, first confirm that the batch or lot number on the COA matches the number on the vial label or outer packaging. If there is no matching reference, there is no clear chain between the result and the item in hand.
Check the product name and stated quantity next. Small naming differences can matter. A COA for a general product name does not automatically validate a differently labelled form, blend or concentration. The document should identify the tested material clearly enough for a purchaser to match it without assumptions.
The analytical test and result should also be visible. For peptide purity, HPLC or UHPLC is commonly used to separate components in a sample and estimate the percentage represented by the main peak. A stated result such as “HPLC purity: 99.2%” is more meaningful when it is accompanied by the method used, test date and chromatogram.
A COA should not look like generic artwork. Look for a batch number, report date, sample identification, result table, testing laboratory details and an authorised sign-off or equivalent report control. Formatting varies between laboratories, but a document with no traceable batch reference, no method and no date provides limited assurance.
Read the chromatogram, not just the percentage
A chromatogram is the visual output of chromatography. It plots detector response over time, with different compounds or components appearing as peaks. The principal peak should be consistent with the target material under the stated method, while additional peaks may indicate related substances, synthesis by-products, degradation products or other detectable components.
For a buyer, the most useful first check is straightforward: does the chromatogram show one clearly dominant peak, and does the reported purity align with the area assigned to that peak? A 99% result would normally be expected to show a principal peak accounting for almost all measured peak area, subject to the laboratory’s calculation method.
Do not overinterpret the image. Peak shape and retention time can be affected by instrument settings, column type, mobile phase, detector and sample preparation. A neat-looking chromatogram is not independent proof of identity. Equally, a chromatogram alone may not reveal compounds that the chosen detector or method does not adequately capture. It is evidence within a method, not a universal test of everything present.
That is why a chromatogram is strongest when paired with mass spectrometry data. HPLC answers the question, “How clean is the separated profile under this method?” Mass analysis helps answer, “Is the principal material consistent with the expected molecular mass?”
Use mass data to support identity
Mass spectrometry, including LC-MS, measures ions associated with a sample and can support identification of the target peptide. The reported mass should be reasonably consistent with the expected molecular weight, allowing for charge states, salts, adducts and the reporting convention used by the laboratory.
A purchaser does not need to become a mass spectrometrist to perform a sensible document check. Look for an expected mass and an observed mass, or an equivalent statement that the sample conforms to the expected molecular mass. If a supplier publishes only a purity figure with no identity evidence, the documentation is incomplete.
For more demanding research procurement, ask whether the testing includes both purity and identity confirmation. This is particularly relevant where products have similar names, where a formulation contains multiple components, or where a peptide’s mass can be confused with a closely related material.
Check whether the result is batch-specific and current
A product-level COA is not the same as a batch-specific COA. Generic documents are sometimes reused across multiple production runs. That may show that a product was tested at some point, but it does not demonstrate that the current stock has the same result.
The best practical control is a direct match between the physical label and the record. The batch number should appear on the vial or its sealed packaging, the COA should use the same number, and the product listing should make clear that batch documentation is available. This creates a usable audit trail for individual buyers, laboratories and stockists.
Test dates deserve attention too. An older COA is not automatically invalid, particularly for correctly stored material within its stated period. However, a current batch should have documentation that makes sense for the production and stock cycle. If dates, batch references or labels do not align, ask for clarification before placing a larger order.
At Blanc Peptides, batch-specific COAs and label-to-document traceability are intended to make this check practical rather than theoretical. The customer should be able to review the record associated with the material received, not rely solely on a general product statement.
Inspect the product and the fulfilment controls
Documentation comes first, but the delivered item should still agree with it. Inspect the label for the product name, stated quantity, batch or lot number and any storage information. Check that the vial, seal and protective packaging are intact and that the label is legible. A damaged parcel is not proof that the contents are unsuitable, but it is a reason to document the condition promptly and contact the supplier.
Consider the following checks together before using a new supplier for repeat or volume purchasing:
- Batch number on the label matches the COA exactly.
- COA identifies the material, analytical method, result and report date.
- Chromatogram supports the stated purity result.
- Mass data or equivalent identity testing supports the expected compound.
- Packaging, label details and dispatch records show controlled handling.
Know the limits of a purity claim
Purity testing has limits, and transparent suppliers should not disguise them. HPLC purity is often calculated using peak area, which may not reflect every impurity equally because different compounds can produce different detector responses. The method may also be designed for a specific purpose, such as assessing related peptide impurities, rather than screening for every possible contaminant.
The required level of scrutiny depends on the research setting. A buyer ordering a small quantity may reasonably focus on traceable batch documentation, purity and identity data. A commercial purchaser, stockist or laboratory working to internal specifications may need further records, such as residual solvent testing, water content, microbiological data, stability information or testing against a written acceptance specification.
Price should be considered in that context. Lower pricing is worthwhile when it comes from efficient sourcing, clear unit quantities and sensible order economics, not from removing the records needed to assess a batch. Comparing like for like means comparing documentation, traceability and stated quantity alongside the price per vial.
A supplier that makes batch records accessible, answers specific document questions and keeps labels aligned with COAs gives you a firmer basis for purchasing decisions. Start with the batch number, follow the evidence through the test result, and only then decide whether the stated purity deserves your confidence.
